ACTRN12620000993998已完成未知
Future Health Today: A pragmatic 12-month cluster randomised controlled trial of quality improvement activities in general practice for patients with chronic kidney disease or high risk of undiagnosed cancer
niversity of Melbourne0 个研究点目标入组 15,373 人开始时间: 2020年10月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15,373
研究概览
简要总结
Analysis still underway
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Educational / counselling / training
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •General practices:
- •Contributing data, or willing to contribute data, to Data for Decisions program
- •See at least 35 adults aged 18 years or older per day, have at least 2,500 active adult patients (attended at least three times in the last two years) recorded in their EMR*, have at least 50 patients that fit cohort definitions for people with CKD not on optimal medications and abnormal test results and additional clinical features placing them at risk of an undiagnosed cancer
- •Employ a practice nurse
- •Utilise EMR (Best Practice, Medical Director or ZedMed software) for recording of clinical consultations, prescription of medications and ordering and receiving pathology results
- •Use Windows 10 as the practice computer operating system and can identify a single workstation on which GRHANITE (the data extraction tool required to extract data for Patron) and FHT can be installed. The workstation must be i5/i7 and 16GB RAM or upgradable to 16GB and cannot be the practice management system server.
- •Have Edge, Chrome or Firefox installed on all computers
- •CKD module:
- •Age 18-80 years old
- •Recorded diagnosis or pathology results consistent with chronic kidney disease in electronic medical record
- •Not prescribed ACE inhibitor or angiotensin receptor blocker and/or statin when indicated according to Kidney Health Australia, RACGP Red Book and National Vascular Disease Prevention Alliance Guidelines
- •Cancer module:
- •Raised platelet count:
- •o Age 40 to 80 years
- •o Most recent Platelet count greater than 400 x 10^9/L
- •o Age 50 to 80 years
- •o Patients with anaemia markers, defined as Haemoglobin less than 130g/L in men and less than 115g/L in women or MCV less than 80fl or MHC less than 27pg or ferritin less than 30µg/L
- •Altered PSA:
- •o Male Aged 40 to less than 50 years of age and PSA greater than 2.0 ng/ml;
- •o Male Aged 50 to 80 years and PSA greater than 3.0 ng/ml
- •*Note regarding number of active patients: COVID-19 is having a significant impact on patient attendance at general practice. As such, the number of active patients per clinic may reduce. The impact of this on general practices will be monitored and the inclusion criteria broadened to patients marked as attending the practice (i.e. not marked as deceased or moved to another practice) if required.
排除标准
- •General practices:
- •Previous participation in FHT pilot and optimisation projects
- •Practice is intending to change to another medical software supplier during the trial period
- •Practice is using a cloud based EMR system that does not have GRHANITE (data extraction tool) installed
- •CKD module:
- •Recorded history of renal transplant
- •Recorded history of chronic dialysis
- •Cancer module:
- •Lung, colorectal, gastro-oesophageal, ovarian or endometrial cancer diagnosis in the previous 5 years
- •Prostate cancer
研究者
相似试验
已完成
不适用
Multicenter, retrospective, observational study to explore treatment pattern of systemic corticosteroids for relapse of non-infectious intermediate and posterior uveitis, and pan-uveitis accompanying with VKH disease or sarcoidosis in daily routine practice.non-infectious intermediate and posterior uveitis, and pan-uveitisJPRN-UMIN000032390AbbVie GK157
招募中
不适用
A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With LBLLymphoma, Non-HodgkinLymphoblastic Lymphoma, ChildhoodPTEN LossNOTCH1 Gene MutationPediatric CancerNCT03971318Sun Yat-sen University300
已完成
不适用
The BioVent - BIOmarkers for mechanically VENTilated patients cohort studyISRCTN59376582niversity Hospital of Basel961
终止
不适用
A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study.SchizophreniaNCT04742413Angelini Farmacéutica9
已完成
不适用
A prospective cohort study on incidence and outcome of patients with post-stroke depression in ChinaPost-stroke depressionMental and Behavioural DisordersISRCTN62169508Beijing Tian Tan Hospital, Capital Medical University (China)2,500